Information regarding Lung Cancer Treatment

Response to this request is long overdue. By law, under all circumstances, Surrey and Borders Partnership NHS Foundation Trust should have responded by now (details). You can complain by requesting an internal review.

Dear Surrey and Borders Partnership NHS Foundation Trust,

I would like to ask the following question regarding lung cancer treatment.

The purpose of these questions is to understand the variability of treatment within your trust and in context to the rest of the country.

Q1. In the past 3 months (or the latest 3 months data you have available), how many metastatic non-small cell lung cancer (NSCLC) patients were treated with any of the following:

• Afatinib
• Alectinib
• Atezolizumab monotherapy
• Atezolizumab in combination
• Bevacizumab
• Brigatinib
• Capmatenib
• Ceritinib
• Crizotinib
• Dacomitinib
• Dabrafenib with Trametinib
• Docetaxel monotherapy
• Durvalumab
• Erlotinib
• Gefitinib
• Gemcitabine
• Nintedanib with Docetaxel
• Nivolumab
• Osimertinib
• Paclitaxel
• Pembrolizumab monotherapy
• Pembrolizumab in combination
• Pemetrexed with Carboplatin/Cisplatin
• Tepotinib
• Vinorelbine with Cisplatin/Carboplatin
• Any other SACT
• Palliative care only

Thank you for taking the time to answer this question and I look forward to hearing from you.

Yours faithfully,

David Elder

IGTeam, Surrey and Borders Partnership NHS Foundation Trust

Due to the unprecedented challenges to Surrey and Borders Partnership NHS
Foundation Trust during the Coronavirus (COVID-19) pandemic, you may
experience a delay in the acknowledgment and/or response to requests
received under the Data Protection Act, 2018 and Freedom of Information
Act, 2000. We apologies for any inconvenience experienced during this
period

IGTeam, Surrey and Borders Partnership NHS Foundation Trust

Your email has been received by the team and we will respond to you as
soon as possible.

 

Regards.

 

IG Team

FOI, Surrey and Borders Partnership NHS Foundation Trust

6 Attachments

Dear David Elder

Thank you for your request for information received on Friday 1 April
2022, a copy of which is below – Our Ref 11217.

Due to the unprecedented challenges to Surrey and Borders Partnership NHS
Foundation Trust during the Coronavirus (COVID-19) pandemic, you may
experience a delay in the acknowledgment and/or response to requests
received under the Data Protection Act, 2018 and Freedom of Information
Act, 2000. We apologise for any inconvenience experienced during this
period.

Surrey and Borders Partnership NHS Foundation Trust is the leading
provider of health and social care services for people of all ages with
mental ill-health and learning disabilities in Surrey & North East
Hampshire and drug & alcohol services in Surrey and Brighton. We also
provide social care services for people with a learning disability in
Croydon and ASD and ADHD assessment services in Hampshire.

The Trust does not deliver metastatic non-small cell lung cancer (NSCLC)
patients services and therefore unable to respond to your request.

This Freedom of Information request is closed.

Yours sincerely

Information Governance Team
01372 216059

 ​
FOI    
    
T:  [1]01372 216059 Surrey and Borders Partnership NHS Foundation Trust
E:  [2][email address]
   
[3]Facebook [4]LinkedIn [5]Twitter [6]YouTube      [7]www.sabp.nhs.uk
 
[8]Here for You website
​This e-mail and any files transmitted with it are confidential and are intended solely for the
use of the individual or entity to whom they are addressed. If you are not the intended
recipient, you are notified that any use, dissemination or copying of this communication is
strictly prohibited. If you have received this e-mail in error please notify the sender and
delete it immediately. Any information, statements or opinions contained in this message
(including any attachments) are given by the author. They are not given on behalf of the Surrey
and Borders Partnership NHS Foundation Trust unless subsequently confirmed by an individual,
other than the author, who is authorised to represent Surrey and Borders Partnership NHS
Foundation Trust.

show quoted sections